F. Khemissa Akouz

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study

Jean–Marc Phelip, Jérôme Desrame, Julien Edeline et al. · Journal of Clinical Oncology · 2021 · 125 citations

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Jean–Louis Jouve, Thierry Lecomte, Olivier Bouché et al. · Journal of Hepatology · 2019 · 106 citations

Oncology, Hepatology, Pravastatin Combination +8

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Thomas Aparicio, Olivier Bouché, E. Maillard et al. · Annals of Oncology · 2017 · 76 citations · Full text

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Thomas Aparicio, Olivier Bouché, E. François et al. · European Journal of Cancer · 2018 · 38 citations

Geriatric Oncology, Geriatrics, Medicine +11

LBA77 5-fluorouracil and oxaliplatin with or without docetaxel in the first-line treatment of HER2 negative locally advanced (LA) unresectable or metastatic gastric or gastro-esophageal junction (GEJ) adenocarcinoma (GASTFOX-PRODIGE 51): A randomized phase III trial sponsored by the FFCD

Aziz Zaanan, Olivier Bouché, Christelle de la Fouchardière et al. · Annals of Oncology · 2023 · 28 citations · Full text

Lba77 5-Fluorouracil, Esophageal Cancer, Gastrointestinal Oncology +8